519054-54-7,
4-methyl-7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydro-2H-1,4-benzoxazine,
4-METHYL-7-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)-3,4-DIHYDRO-2H-BENZO[B][1,4]OXAZINE,
4-methyl-7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2,3-dihydro-1,4-benzoxazine,
AC1MDT23,
SCHEMBL426125,
CTK4J5077,
DTXSID90383617,
QRAOZQGIUIDZQZ-UHFFFAOYSA-N,
MFCD04115377,
AKOS024260454,
ZINC169743688,
AB19951,
FCH2718832,
RP06552,
ACM519054547,
AS-55106,
OR360005,
SC-65679,
AX8098957,
DB-026254,
CS-0091166,
FT-0711332,
Y9304,
Z-5348,
J-515771,
I14-106288,
4-METHYL-7-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN,
4-METHYL-3,4-DIHYDRO-2H-1,4-BENZOXAZIN-7-YLBORONIC ACID PINACOL ESTER,
4-methyl-7-(tetramethyl-1,3,2-dioxaborolan-2-yl)-2,3-dihydro-1,4-benzoxazine,
4-methyl-7-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-3,4-dihydro-2h-1,4-benzoxazine,
4-methyl-7-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-3,4-dihydro-2H-benzo[1,4]oxazine,
4-Methyl-7-(4,4,5,5-tetramethyl-1,3,2,-dioxaborolan-2-yl)-3,4-dihydro-2H-1,4-benzoxazine,
4-methyl-7-(4,4,5,5-tetramethyl-1,3,2-d ioxaborolan-2-yl)-3,4-dihydro-2H-benzo[b][1,4]oxazine,
C15H22BNO3,
CID2795301,
CID 2795301,